Optomed joins forces with Commit
Optomed, manufacturer of hand-held fundus cameras and solutions for screening of blinding eye diseases, has acquired Commit;, a company specializing in healthcare software solutions. With the acquisition these two companies form a strong international provider of complete solutions for screening of different diseases.
The merger enables serving the customer base of both companies better than before and investing more in research and development as well as international growth.
“By joining forces with Commit;, we can offer complete and proven solutions for screening of diabetic retinopathy and other diseases. Finland has implemented one of the best working screening programs in the world within last couple of decades. They are mostly run on Commit;’s screening platforms. We see great international potential for these solutions among our customers,” said Seppo Kopsala, CEO of Optomed.
Markku Myllylä, CEO of Commit; added: “Optomed’s global sales network opens significant new opportunities to grow for Commit;’s business internationally.”
With this acquisition both Optomed’s and Commit;’s current services, functions and personnel’s roles remain unchanged. Also sales and support of Sectra products remains integral and very important part of Commit;’s business in Finland, and it will continue as before.